|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 71.82 GBX | +4.85% |
|
+12.09% | +22.72% |
| 24/02 | Avacta hails new data supporting proprietary preCision platform | AN |
| 24/02 | Avacta Therapeutics Plans FAP-Exd's Clinical Trials After 'Favorable' Experimental Analysis | MT |
| Capitalization | 30Cr 40Cr 34Cr 31Cr 55Cr 3.69TCr 57Cr 367.01Cr 146.95Cr 1.76TCr 150.28Cr 147.05Cr 6.29TCr | P/E ratio 2025 * |
-9.97x | P/E ratio 2026 * | -11.6x |
|---|---|---|---|---|---|
| Enterprise value | 29Cr 39Cr 34Cr 31Cr 54Cr 3.62TCr 56Cr 360.36Cr 144.28Cr 1.73TCr 147.56Cr 144.39Cr 6.17TCr | EV / Sales 2025 * |
47.1x | EV / Sales 2026 * | - |
| Free-Float |
66.47% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Avacta Group Plc
| 10/24/10 | Deutsche Bank Upgrades Avacta Group to Hold | MT |
| 10/24/10 | RBC raises Hikma; JPMorgan cuts Schroders | AN |
| 17/24/17 | Deutsche Bank Downgrades Avacta Group to Sell | MT |
| 17/24/17 | Berenberg, Peel cut TT Electronics to 'hold' | AN |
| 19/24/19 | Deutsche Raises Avacta to Hold from Sell | MT |
| 1 day | +3.91% | ||
| 1 week | +12.09% | ||
| Current month | +5.45% | ||
| 1 month | +18.63% | ||
| 3 months | -9.90% | ||
| 6 months | +24.88% | ||
| Current year | +22.72% |
| 1 week | 60 |  | 74 |
| 1 month | 53 | | 74 |
| Current year | 48 | | 74 |
| 1 year | 26 | | 84 |
| 3 years | 26 | | 166.98 |
| 5 years | 26 | | 291.8 |
| 10 years | 13 | | 291.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 01/04/2024 | |
Brian Hahn
DFI | Director of Finance/CFO | 51 | 22/01/2025 |
| Chief Tech/Sci/R&D Officer | - | 09/02/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Paul Fry
BRD | Director/Board Member | 60 | 03/02/2020 |
Mark Goldberg
BRD | Director/Board Member | 71 | 17/08/2021 |
| Director/Board Member | 56 | 18/03/2022 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.85% | +12.09% | +98.82% | -44.30% | 40Cr | |
| +0.81% | -0.67% | +9.35% | +101.37% | 4.57TCr | |
| -1.85% | -7.84% | +52.40% | +10.53% | 3.98TCr | |
| +1.96% | +0.85% | +94.12% | +627.57% | 3.23TCr | |
| +3.02% | -5.50% | -5.34% | -20.62% | 2.6TCr | |
| +0.40% | -7.42% | +53.42% | -38.10% | 1.87TCr | |
| +1.06% | -1.39% | +9.34% | -29.20% | 1.72TCr | |
| +7.03% | +0.10% | +38.87% | +134.75% | 1.12TCr | |
| +1.79% | -1.91% | -19.43% | +898.70% | 1.19TCr | |
| +2.33% | -6.84% | +8.88% | +143.09% | 1.08TCr | |
| Average | +2.05% | -4.13% | +34.04% | +178.38% | 2.14TCr | |
| Weighted average by Cap. | +1.21% | -6.09% | +32.29% | +174.39% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 62.5L 83.51L 71.81L 65.17L 1.14Cr 77Cr 1.18Cr 7.66Cr 3.07Cr 37Cr 3.13Cr 3.07Cr 131.13Cr | - |
| Net income | -3.51Cr -4.69Cr -4.04Cr -3.66Cr -6.41Cr -432.67Cr -6.65Cr -43Cr -17Cr -206.34Cr -18Cr -17Cr -736.94Cr | -3.15Cr -4.22Cr -3.63Cr -3.29Cr -5.76Cr -388.62Cr -5.97Cr -39Cr -15Cr -185.33Cr -16Cr -15Cr -661.93Cr |
| Net Debt | -54.32L -72.58L -62.41L -56.64L -99.19L -67Cr -1.03Cr -6.65Cr -2.66Cr -32Cr -2.72Cr -2.67Cr -113.96Cr | 1.68Cr 2.25Cr 1.93Cr 1.75Cr 3.07Cr 206.98Cr 3.18Cr 21Cr 8.24Cr 99Cr 8.43Cr 8.25Cr 352.54Cr |
Employees
151
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/26/05 | 71.82 p | +4.85% | 13,15,188 |
| 04/26/04 | 68.50 p | +10.48% | 17,91,840 |
| 03/26/03 | 62.00 p | 0.00% | 15,02,115 |
| 02/26/02 | 62.00 p | -8.15% | 25,82,192 |
| 27/26/27 | 67.50 p | +6.30% | 30,49,645 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.6850GBP
Average target price
0.8000GBP
Spread / Average Target
+16.79%
Annual profits - Rate of surprise
- Stock Market
- Equities
- AVCT Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition